share_log

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KKR Genetic Disorder L.P.(13.4%),KKR Genetic Disorder GP LLC(13.4%), etc.

BridgeBio Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-KKR Genetic Disorder L.P.(13.4%),KKR Genetic Disorder GP LLC(13.4%)等

美股SEC公告 ·  2024/09/18 06:45
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息